STAB Company Profile and Key Details
Statera Biopharma, Inc.
STAB Stock Price Chart
Stock Price Today
Statera Biopharma, Inc. (STAB) stock remained unchanged at $0.00 a share on NASDAQ. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as expanding into fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. The company is based in Fort Collins, Colorado.
Company Information
| Employees | 46 |
| Beta | 261.46 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Statera Biopharma, Inc. (NASDAQ: STAB) stock price is $0.00 in the last trading session. During the trading session, STAB stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in STAB stock occurred in the recent session was 0% while the dollar amount for the price change in STAB stock was -.
The NASDAQ listed STAB is part of Biotechnology industry that operates in the broader Healthcare sector. Statera Biopharma, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Michael Kevin Handley
Chief Executive Officer, Pres & Chairman
George Wagner
Executive Vice President of Regulatory Affairs
Dr. Robert W. Buckheit Jr., Ph.D.
Chief Technology Officer
Todd Headley
Executive Vice President of Corporation Devel.
Mr. Christopher Zosh
Executive Vice President of Fin., Interim Principal Financial Officer & Interim Principal Accounting Officer
STAB's closing price is 0% higher than its 52-week low of $0.00 where as its distance from 52-week high of $0.13 is -99.92%.
Number of STAB employees currently stands at 46.
Official Website of STAB is: https://www.staterabiopharma.com
STAB could be contacted at phone 888 613 8802 and can also be accessed through its website. STAB operates from 2537 Research Boulevard, Fort Collins, CO 80526, United States.
STAB stock volume for the day was 100 shares. The average number of STAB shares traded daily for last 3 months was 23.97K.
The market value of STAB currently stands at $7.14K with its latest stock price at $0.00 and 71.42M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com